{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T05:15:36Z","timestamp":1779167736826,"version":"3.51.4"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    We present a case involving a 62-year-old man diagnosed with acinar-type prostate adenocarcinoma, who was referred for initial staging with\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-PSMA scintigraphy. Considering the metastatic lesions exhibited low PSMA avidity, a\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-FAPI-46 scintigraphy was conducted to improve the detection of metastases and to potentially facilitate future radio-ligand therapy using FAP-targeted radiopharmaceuticals. In this experience,\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-FAPI-46 demonstrated superior diagnostic performance compared with\n                    <jats:sup>99m<\/jats:sup>\n                    Tc-PSMA scintigraphy, underscoring its potential utility in cases where tumors exhibit low PSMA expression or when tumor heterogeneity is suspected.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000006005","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T16:06:35Z","timestamp":1749139595000},"page":"e250-e251","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Superior Performance of 99mTc-FAPI SPECT\/CT Compared With 99mTc-PSMA Scintigraphy in the Initial Staging of Prostate Cancer: A Case Report"],"prefix":"10.1097","volume":"51","author":[{"given":"Amin","family":"Saber Tanha","sequence":"first","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nasrin","family":"Raeisi","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farid","family":"Jafari Zarrin Ghabaei","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamidreza","family":"Ghorbani","sequence":"additional","affiliation":[{"name":"Department of Urology, Imam Reza hospital, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2973-2251","authenticated-orcid":false,"given":"Emran","family":"Askari","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Research Center, Mashhad University of Medical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"key":"R1-20260305","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12967-025-06071-8","article-title":"Cancer-associated fibroblasts in carcinogenesis","volume":"23","author":"Zhou","year":"2025","journal-title":"J Transl Med"},{"key":"R2-20260305","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1097\/RLU.0000000000005348","article-title":"Recent clinical implications of FAPI","volume":"49","author":"Kiani","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R3-20260305","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1097\/RLU.0000000000004825","article-title":"Fibroblast activation protein\u2013targeted PET\/CT imaging in a treatment-naive prostate cancer patient with low PSMA expression","volume":"48","author":"Mu","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R4-20260305","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/RLU.0000000000004349","article-title":"68Ga-FAPI PET\/CT detected non\u2013PSMA\/FDG-avid primary tumor in de novo metastatic prostate cancer","volume":"47","author":"Pang","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R5-20260305","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/RLU.0000000000004315","article-title":"68Ga-FAPI-46 PET\/CT in a metastatic castration-resistant prostate cancer patient with low PSMA expression","volume":"47","author":"Aryana","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R6-20260305","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1097\/RLU.0000000000003837","article-title":"Fibroblast activation protein\u2013targeted PET imaging of metastatic castration-resistant prostate cancer compared with 68Ga-PSMA and 18F-FDG PET\/CT","volume":"47","author":"Isik","year":"2022","journal-title":"Clin Nucl Med"},{"key":"R7-20260305","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/RLU.0000000000004719","article-title":"Visualization of intermetastatic heterogeneity in mixed neuroendocrine carcinoma\u2013acinar adenocarcinoma of the prostate by 68Ga-PSMA, 68Ga-FAPI, and 18F-FDG PET\/CT","volume":"48","author":"Cai","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R8-20260305","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1097\/RLU.0000000000005522","article-title":"99mTc-PSMA and 99mTc-FAPI-46 uptake in pulmonary lymphangitic carcinomatosis","volume":"49","author":"Raeisi","year":"2024","journal-title":"Clin Nucl Med"},{"key":"R9-20260305","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/RLU.0000000000003099","article-title":"68Ga-FAPI PET\/CT detects gastric signet-ring cell carcinoma in a patient previously treated for prostate cancer","volume":"45","author":"Pang","year":"2020","journal-title":"Clin Nucl Med"},{"key":"R10-20260305","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/RLU.0000000000004635","article-title":"Solitary fibrous tumor of the prostate shown on FAPI PET\/CT","volume":"48","author":"Yang","year":"2023","journal-title":"Clin Nucl Med"},{"key":"R11-20260305","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/RLU.0000000000005599","article-title":"Adult embryonal rhabdomyosarcoma of the prostate presented on 18F-FDG and Al18F-FAPI-74 PET\/CT","volume":"50","author":"Cheng","year":"2025","journal-title":"Clin Nucl Med"},{"key":"R12-20260305","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1097\/RLU.0000000000004550","article-title":"68Ga-FAPI-04 PET\/CT in primary signet ring\u2013like cell carcinoma of prostate with bone metastases","volume":"48","author":"Tatar","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T21:02:50Z","timestamp":1772744570000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000006005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000006005","relation":{},"ISSN":["0363-9762","1536-0229"],"issn-type":[{"value":"0363-9762","type":"print"},{"value":"1536-0229","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]},"assertion":[{"value":"2025-03-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}